Purchase Order 75D30123P17530
Award Date
8/9/23
Potential Completion Date
9/30/23
Potential Value
$247K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $35,041.35, is for the delivery of DNA reagents with a completion date of September 20, 2024. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...
This is a $80,453.34 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract is for the provision of reagent products to support the CDC's genomic sequencing and analysis work. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, USDA, and VA for research and diagnostics. This award does not have...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $156,549.12, is for the delivery of reagents. There is no set-aside designation for this award. Illumina has previously received prime federal contracts and sub-awards from various agencies, including the National Institutes of Health (NIH),...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $75,775.80 contract is for the provision of Illumina MiSeq reagents to support the agency's genomic sequencing and analysis needs. The contract has no set-aside designation. Illumina has previously provided a range of sequencing systems, consumables, and services to support...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $87,570.20, is for the provision of NextGen sequencing genomes, with an ultimate completion date of October 31, 2015. Illumina has previously received prime federal contracts and subcontracts from agencies like the...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...